Measurement of kappa:lambda light chain ratios by haemagglutination techniques.
Haemagglutination techniques are described for quantitating kappa:lambda ratios in human immunoglobulin. The techniques have been evaluated using monoclonal light chains from myeloma patients, but are applicable to a variety of clinical situations.
D000818:Animals; D001536:Bence Jones Protein / Q000652:urine; D001769:Blood; D004912:Erythrocytes / Q000276:immunology; D005976:Glutaral; D006041:Goats / Q000276:immunology; D006385:Hemagglutination Inhibition Tests; D006386:Hemagglutination Tests / Q000379:methods*; D006801:Humans; D007106:Immune Sera; D005779:Immunodiffusion; D007128:Immunoglobulin Fragments / Q000032:analysis*; D007145:Immunoglobulin kappa-Chains / Q000032:analysis*; D007146:Immunoglobulin lambda-Chains / Q000032:analysis*; D016030:Kidney Transplantation; D007938:Leukemia / Q000276:immunology; D008180:Lupus Erythematosus, Systemic / Q000276:immunology; D008223:Lymphoma / Q000276:immunology; D009103:Multiple Sclerosis / Q000276:immunology; D011817:Rabbits / Q000276:immunology; D012756:Sheep / Q000276:immunology; D014184:Transplantation, Homologous
D007106:Immune Sera; D007128:Immunoglobulin Fragments; D007145:Immunoglobulin kappa-Chains; D007146:Immunoglobulin lambda-Chains; D001536:Bence Jones Protein; D005976:Glutaral